mhurhangee/patent-ind-claim-en huggingface dataset:
A method for switching between two or more electrical power sources, the method comprising: receiving an instruction to switch from a first input line to a second input line , wherein the first input line is electrically connected to an output line via a first switch assembly, wherein the first switch assembly comprises a first latching relay in parallel with a first solid-state relay , and wherein the second input line is electrically connectible with the output line via a second switch assembly comprising a second solid-state relay in parallel with a non-latching relay ; causing, at the first switch assembly, the first solid-state relay to close such that the first latching relay is short circuited; causing the first latching relay to open while the first latching relay is shorted by the first solid-state relay; causing the first solid-state relay to open such that the first input line becomes electrically disconnected from the output line; and causing, at the second switch assembly, the non-latching relay to close such that the second input line becomes electrically connected with the output line. receiving an instruction to switch from a first input line to a second input line , wherein the first input line is electrically connected to an output line via a first switch assembly, wherein the first switch assembly comprises a first latching relay in parallel with a first solid-state relay , and wherein the second input line is electrically connectible with the output line via a second switch assembly comprising a second solid-state relay in parallel with a non-latching relay ; causing, at the first switch assembly, the first solid-state relay to close such that the first latching relay is short circuited; causing the first latching relay to open while the first latching relay is shorted by the first solid-state relay; causing the first solid-state relay to open such that the first input line becomes electrically disconnected from the output line; and causing, at the second switch assembly, the non-latching relay to close such that the second input line becomes electrically connected with the output line.
A bioactive molecule-containing liposome formulation for use in a method of treating, ameliorating or preventing an ocular disease or dysfunction by administering the formulation to the eye of a subject by iontophoresis, wherein the bioactive molecule is selected from the group consisting of lutein and/or zeaxanthin and the liposome has a positive zeta potential.
A curable epoxy resin composition comprising: (a) at least one epoxy resin compound, (b) at least one curing agent, (c) at least one curing accelerator, (d) at least one internal mold release agent; and (e) at least one reaction inhibitor.
A method of determining the identity of a fluid in a vessel using time domain reflectometry, comprising the steps of: transmitting an interrogation pulse into a vessel containing a fluid ; receiving a reflection of the interrogation pulse off of a transition boundary ; characterised in that the method further comprises the steps of: characterizing the properties of the reflection, where the properties comprise change in phase, change in slope, and relative amplitude together forming a boundary transition signature; and comparing the properties of the boundary transition signature to a reference boundary transition signature, wherein a match or near match of the boundary transition signature and the reference boundary transition signature is used to determine the identity of a fluid on one side of the transition boundary . transmitting an interrogation pulse into a vessel containing a fluid ; receiving a reflection of the interrogation pulse off of a transition boundary ; characterizing the properties of the reflection, where the properties comprise change in phase, change in slope, and relative amplitude together forming a boundary transition signature; and comparing the properties of the boundary transition signature to a reference boundary transition signature, wherein a match or near match of the boundary transition signature and the reference boundary transition signature is used to determine the identity of a fluid on one side of the transition boundary .
A bronchoscopy system configured to perform automatic landmark registration during a bronchoscopy procedure, the bronchoscopy system comprising: a processor operatively coupled to a catheter and a visual display device; the processor configured to generate a map of airways of a lung based on a pre-operative image of the lung, wherein the map can be displayed on a visual display; the processor configured to generate a segmentation centerline of the airways of the lung based on the pre-operative image of the lung; the processor configured to automatically detect a first plurality of landmarks on the segmentation centerline, wherein the first plurality of landmarks correspond to bifurcations in the airways of the lung; the processor configured to generate a location data point cloud based on locations of the catheter during navigation through the airways of the lung; the processor configured to generate a bounding volume of the airways of the lung based on the location data point cloud; the processor configured to detect a bounding volume centerline from the bounding volume of the airways of the lung; the processor configured to automatically detect a second plurality of landmarks on the bounding volume centerline corresponding to the bifurcations of the first plurality of landmarks; and the processor configured to generate a mapping of the first plurality of landmarks to corresponding points in the second plurality of landmarks and use the mapping to integrate the location data point cloud with the map of the airways of the lung. a processor operatively coupled to a catheter and a visual display device; the processor configured to generate a map of airways of a lung based on a pre-operative image of the lung, wherein the map can be displayed on a visual display; the processor configured to generate a segmentation centerline of the airways of the lung based on the pre-operative image of the lung; the processor configured to automatically detect a first plurality of landmarks on the segmentation centerline, wherein the first plurality of landmarks correspond to bifurcations in the airways of the lung; the processor configured to generate a location data point cloud based on locations of the catheter during navigation through the airways of the lung; the processor configured to generate a bounding volume of the airways of the lung based on the location data point cloud; the processor configured to detect a bounding volume centerline from the bounding volume of the airways of the lung; the processor configured to automatically detect a second plurality of landmarks on the bounding volume centerline corresponding to the bifurcations of the first plurality of landmarks; and the processor configured to generate a mapping of the first plurality of landmarks to corresponding points in the second plurality of landmarks and use the mapping to integrate the location data point cloud with the map of the airways of the lung.
A compound of Formula (I), an enantiomer thereof, a diastereomer thereof, or a pharmaceutically acceptable salt thereof. wherein: An is wherein R 1 , R 2 , R 4 and R 5 each is fluorine and R 3 is hydrogen; Ar 2 is selected from Q is 0; M 1 is piperidinyl or pyrrolidinyl; Y is C(=O), NHC(=O), NR 11 C(=O) or S(=O) 2 ; and R 10 , R 11 can be independently selected from amino, cycloamino, aryl, heteroaryl, heterocycloalkyl, oxo-heterocyclyl, trifluoromethyl, trifluoromethoxy, trifluoroacetyl, amide group, acyl, guanidyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkyl, C 3 -C 10 cycloalkyl, C 1 -C 6 alkoxyl, C 1 -C 6 oxoalkyl; wherein the amino, amide group, acyl, C 2 -C 6 alkenyl, alkyl, alkoxyl or cycloalkyl can be further optionally substituted with deuterium, halogen, amino, hydroxy, hydroxy alkyl, carbonyl, ester group, amide group, nitro, cyano, trifluoroacetyl, trifluoromethyl, trifluoromethoxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxyl, C 1 -C 6 oxoalkyl, C 3 -C 10 cycloalkyl. An is wherein R 1 , R 2 , R 4 and R 5 each is fluorine and R 3 is hydrogen; Ar 2 is selected from Q is 0; M 1 is piperidinyl or pyrrolidinyl; Y is C(=O), NHC(=O), NR 11 C(=O) or S(=O) 2 ; and R 10 , R 11 can be independently selected from amino, cycloamino, aryl, heteroaryl, heterocycloalkyl, oxo-heterocyclyl, trifluoromethyl, trifluoromethoxy, trifluoroacetyl, amide group, acyl, guanidyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkyl, C 3 -C 10 cycloalkyl, C 1 -C 6 alkoxyl, C 1 -C 6 oxoalkyl; wherein the amino, amide group, acyl, C 2 -C 6 alkenyl, alkyl, alkoxyl or cycloalkyl can be further optionally substituted with deuterium, halogen, amino, hydroxy, hydroxy alkyl, carbonyl, ester group, amide group, nitro, cyano, trifluoroacetyl, trifluoromethyl, trifluoromethoxy, C 1 -C 6 alkyl, C 1 -C 6 alkoxyl, C 1 -C 6 oxoalkyl, C 3 -C 10 cycloalkyl.
An antibody capable of specifically binding to IL-17A or a functional fragment capable of specifically binding to IL-17A thereof, wherein the antibody or the functional fragment thereof comprise a light chain and a heavy chain; the light chain comprises a light chain CDR consisting of CDR-L1, CDR-L2 and CDR-L3; the heavy chain comprises a heavy chain CDR consisting of CDR-H1, CDR-H2 and CDR-H3; the amino acid sequences of the CDR-L1, CDR-L2 and CDR-L3 are respectively set forth in SEQ ID NO: 1, 2 and 3; the amino acid sequences of the CDR-H1, CDR-H2 and CDR-H3 are respectively set forth in SEQ ID NO: 4, 5 and 6; preferably, the antibody or the functional fragment thereof includes an IL-17A chimeric antibody or a functional fragment thereof, and an IL-17A humanized antibody or a functional fragment thereof. the light chain comprises a light chain CDR consisting of CDR-L1, CDR-L2 and CDR-L3; the heavy chain comprises a heavy chain CDR consisting of CDR-H1, CDR-H2 and CDR-H3; the amino acid sequences of the CDR-L1, CDR-L2 and CDR-L3 are respectively set forth in SEQ ID NO: 1, 2 and 3; the amino acid sequences of the CDR-H1, CDR-H2 and CDR-H3 are respectively set forth in SEQ ID NO: 4, 5 and 6; preferably, the antibody or the functional fragment thereof includes an IL-17A chimeric antibody or a functional fragment thereof, and an IL-17A humanized antibody or a functional fragment thereof.
A method for preparing a graft copolymer, the method comprising: 1) preparing a seed by adding one or more selected from the group consisting of an alkyl (meth)acrylate-based monomer, an aromatic vinyl-based monomer, and a vinyl cyan-based monomer and carrying out polymerization; 2) preparing a core in the presence of the seed by adding an alkyl (meth)acrylate-based monomer and carrying out polymerization; and 3) preparing a shell in the presence of the core by adding an aromatic vinyl-based monomer and a vinyl cyan-based monomer and carrying out polymerization, wherein an activator including a compound represented by Chemical Formula 1 is added in 3), and wherein the core has an average particle diameter of 320 nm to 520 nm, measured by a dynamic light scattering method using a particle size analyzer. In Chemical Formula 1, R 1 and R 2 , which are the same or different from each other, are each independently hydrogen, a C 1 -C 10 alkyl group, or *-(C=O)OM 2 , provided that R 1 and R 2 are not both hydrogen, and M 1 and M 2 , which are the same or different from each other, are each independently an alkali metal. 1) preparing a seed by adding one or more selected from the group consisting of an alkyl (meth)acrylate-based monomer, an aromatic vinyl-based monomer, and a vinyl cyan-based monomer and carrying out polymerization; 2) preparing a core in the presence of the seed by adding an alkyl (meth)acrylate-based monomer and carrying out polymerization; and 3) preparing a shell in the presence of the core by adding an aromatic vinyl-based monomer and a vinyl cyan-based monomer and carrying out polymerization, R 1 and R 2 , which are the same or different from each other, are each independently hydrogen, a C 1 -C 10 alkyl group, or *-(C=O)OM 2 , provided that R 1 and R 2 are not both hydrogen, and M 1 and M 2 , which are the same or different from each other, are each independently an alkali metal.
A computer implemented method, comprising: receiving a depth map of a scene and a corresponding active brightness image of the scene, wherein the active brightness image can show brightness levels of individual regions and/or pixels of the depth camera's sensors; detecting blooming in the depth map at least in part from saturated pixels in the active brightness image; identifying a depth range of the saturated pixels, comprising: computing a set of all valid depth pixels that have a spatial neighbor that is saturated, generating a histogram of depth values for the set and smoothing the histogram, and computing the largest sequence of consecutive bins in the smoothed histogram where each bin of that sequence has a count larger than 0; invalidating the depth range of the saturated pixels from the depth map; and, generating another depth map that includes invalidated depths for the saturated pixels. receiving a depth map of a scene and a corresponding active brightness image of the scene, wherein the active brightness image can show brightness levels of individual regions and/or pixels of the depth camera's sensors; detecting blooming in the depth map at least in part from saturated pixels in the active brightness image; identifying a depth range of the saturated pixels, comprising: computing a set of all valid depth pixels that have a spatial neighbor that is saturated, generating a histogram of depth values for the set and smoothing the histogram, and computing the largest sequence of consecutive bins in the smoothed histogram where each bin of that sequence has a count larger than 0; computing a set of all valid depth pixels that have a spatial neighbor that is saturated, generating a histogram of depth values for the set and smoothing the histogram, and computing the largest sequence of consecutive bins in the smoothed histogram where each bin of that sequence has a count larger than 0; invalidating the depth range of the saturated pixels from the depth map; and, generating another depth map that includes invalidated depths for the saturated pixels.
A method of manufacturing a valve body having one or more corrosion-resistant internal surfaces , the method comprising: performing a casting process, comprising pouring a first molten metal material into a mold box to produce a valve body casting made of the first material; and during the casting process, forming a layer of a second material on one or more internal surfaces of the valve body casting , the second material having a higher corrosion resistance than the first material, wherein forming the layer comprises: applying, with an additive manufacturing technique, the second material to one or more external surfaces of a core ; and inserting the core into the mold box , wherein a portion of the first material binds to the second material on the one or more external surfaces of the core while the first material is poured into the mold box . performing a casting process, comprising pouring a first molten metal material into a mold box to produce a valve body casting made of the first material; and during the casting process, forming a layer of a second material on one or more internal surfaces of the valve body casting , the second material having a higher corrosion resistance than the first material, wherein forming the layer comprises: applying, with an additive manufacturing technique, the second material to one or more external surfaces of a core ; and inserting the core into the mold box , wherein a portion of the first material binds to the second material on the one or more external surfaces of the core while the first material is poured into the mold box . applying, with an additive manufacturing technique, the second material to one or more external surfaces of a core ; and inserting the core into the mold box , wherein a portion of the first material binds to the second material on the one or more external surfaces of the core while the first material is poured into the mold box .
A patient support for use in a healthcare facility having at least one secondary patient support, the patient support comprising: a display operable to render a graphical user interface (GUI) to interface with a user and allow the user to set one or more alarms, wherein each alarm corresponds to an alarm triggering event triggered by an action of a patient; communication circuitry to communicatively couple the patient support to a healthcare communication system and the patient support to the at least one secondary patient support ; and a control system to monitor data of the patient support and the at least one secondary patient support based on the set alarms, detect whether an alarm triggering event occurred at either the patient support or the at least one secondary patient support based on the monitored data, and, in response to a determination that the alarm triggering event occurred, provide a signal indicative of the alarm triggering event to the healthcare communication system , wherein the GUI is further configured to facilitate a wireless network connection for wireless transfer of alarm data between the patient support and the at least one secondary patient support, characterized in that the GUI of the patient support has a user input for setting an alarm of the at least one secondary patient support a display operable to render a graphical user interface (GUI) to interface with a user and allow the user to set one or more alarms, wherein each alarm corresponds to an alarm triggering event triggered by an action of a patient; communication circuitry to communicatively couple the patient support to a healthcare communication system and the patient support to the at least one secondary patient support ; and a control system to monitor data of the patient support and the at least one secondary patient support based on the set alarms, detect whether an alarm triggering event occurred at either the patient support or the at least one secondary patient support based on the monitored data, and, in response to a determination that the alarm triggering event occurred, provide a signal indicative of the alarm triggering event to the healthcare communication system , wherein the GUI is further configured to facilitate a wireless network connection for wireless transfer of alarm data between the patient support and the at least one secondary patient support, characterized in that the GUI of the patient support has a user input for setting an alarm of the at least one secondary patient support
A mixture of isolated peptides comprising three or more different isolated peptides, wherein each isolated peptide comprises a sequence selected from SEQ ID NOs: 3-146, wherein each isolated peptide further comprises: an additional N-terminal peptide sequence wherein the sequence is n 1 -n 2 -S-P-n 5 -n 6 -P (SEQ ID NO: 149), wherein n 1 is an amino acid selected from the group consisting of A and V, n 2 is an amino acid selected from the group consisting of E and D, n 5 is an amino acid selected from the group consisting of K and R, and n 6 is an amino acid selected from the group consisting of K and R; and an additional C-terminal peptide sequence wherein the sequence is: (i) V-c 2 -E-G-c 5 -Q-Q-E-G-A-Q-Q-P-S-C (SEQ ID NO: 150), wherein c 2 is an amino acid selected from the group consisting of Q and R, and c 5 is an amino acid selected from the group consisting of V and A; or (ii) A-V-c 3 -E-G-c 6 -Q-Q-E-G-A-Q-Q-P-S (SEQ ID NO: 151), wherein C 3 is an amino acid selected from the group consisting of Q and R, and C 6 is an amino acid selected from the group consisting of V and A. an additional N-terminal peptide sequence wherein the sequence is n 1 -n 2 -S-P-n 5 -n 6 -P (SEQ ID NO: 149), wherein n 1 is an amino acid selected from the group consisting of A and V, n 2 is an amino acid selected from the group consisting of E and D, n 5 is an amino acid selected from the group consisting of K and R, and n 6 is an amino acid selected from the group consisting of K and R; and an additional C-terminal peptide sequence wherein the sequence is: (i) V-c 2 -E-G-c 5 -Q-Q-E-G-A-Q-Q-P-S-C (SEQ ID NO: 150), wherein c 2 is an amino acid selected from the group consisting of Q and R, and c 5 is an amino acid selected from the group consisting of V and A; or (ii) A-V-c 3 -E-G-c 6 -Q-Q-E-G-A-Q-Q-P-S (SEQ ID NO: 151), wherein C 3 is an amino acid selected from the group consisting of Q and R, and C 6 is an amino acid selected from the group consisting of V and A. (i) V-c 2 -E-G-c 5 -Q-Q-E-G-A-Q-Q-P-S-C (SEQ ID NO: 150), wherein c 2 is an amino acid selected from the group consisting of Q and R, and c 5 is an amino acid selected from the group consisting of V and A; or (ii) A-V-c 3 -E-G-c 6 -Q-Q-E-G-A-Q-Q-P-S (SEQ ID NO: 151), wherein C 3 is an amino acid selected from the group consisting of Q and R, and C 6 is an amino acid selected from the group consisting of V and A.
A feeding assembly for an agricultural vehicle , comprising: a pickup comprising a pickup reel carrying a plurality of tines ; a rotor comprising a plurality of rotor fins disposed rearwardly from the pickup ; and a windguard assembly comprising a pair of movable support arms and a windguard coupled to the support arms , the windguard comprising a tube and a plurality of windguard tines coupled to the tube , the windguard being movable from a first position to a second position that is elevated relative to the first position; a windguard retainer configured to engage the windguard when the windguard is in the second position and retain the windguard in the second position, wherein the windguard tines are configured to move without moving an entirety of the windguard while the windguard is in the second position, and wherein the support arms are pivotable about a first axis of rotation (AR1) and the windguard tines are pivotable about a second axis of rotation (AR2) that is non-coaxial with the first axis of rotation (AR1), the windguard tines being configured to pivot toward and/or away from the pickup to dislodge a crop material blockage; characterized by : an actuator configured to selectively activate and pivot at least one of the windguard tines without moving the entirety of the windguard . a pickup comprising a pickup reel carrying a plurality of tines ; a rotor comprising a plurality of rotor fins disposed rearwardly from the pickup ; and a windguard assembly comprising a pair of movable support arms and a windguard coupled to the support arms , the windguard comprising a tube and a plurality of windguard tines coupled to the tube , the windguard being movable from a first position to a second position that is elevated relative to the first position; a windguard retainer configured to engage the windguard when the windguard is in the second position and retain the windguard in the second position, wherein the windguard tines are configured to move without moving an entirety of the windguard while the windguard is in the second position, and wherein the support arms are pivotable about a first axis of rotation (AR1) and the windguard tines are pivotable about a second axis of rotation (AR2) that is non-coaxial with the first axis of rotation (AR1), the windguard tines being configured to pivot toward and/or away from the pickup to dislodge a crop material blockage;
A method of controlling undesired vegetation comprising applying to a locus of the undesired vegetation a herbicidally effective amount of bifenox and florasulam esters, salts and/or combinations thereof jointly or in a succession or as a mixture comprising bifenox and florasulam esters, salts and/or combinations thereof, wherein bifenox is applied at a rate of between 400 g/ha to 550 g/ha, and florasulam is applied at a rate of between 1 g/ha to 10 g/ha.